Skip to content

AFP Screening in Patients with Hepatitis C

April 24, 2014
tags: ,

Positive predictive value for hepatocellular cancer was low; AFP screening is not recommended.

Recent guidelines recommend against serum α-fetoprotein (AFP) testing to screen for hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (Hepatology 2011; 53:1020). Nevertheless, I still encounter cases in which clinicians have conducted AFP screening. In this study of 855 patients with histologically advanced chronic hepatitis C, researchers measured levels of AFP and two other biomarkers (AFP-L3 and des-γ-carboxy prothrombin [DCP]) every 3 months for 4 years. Patients also underwent yearly screening ultrasound imaging. HCC developed in 46 patients (5% of the cohort).

α-Fetoprotein Screening in Patients with Hepatitis C – NEJM Journal Watch.

 

No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: